Glucagon · 2026 05 31
Inflammatory Cytokines Impair Glucagon Expression and Secretion in Pancreatic α-Cells.
Journal Article
Open attributed record →PubMed-attributed venue
Diabetes, obesity & metabolism
13 selected PubMed bibliographic records attributed to Diabetes, obesity & metabolism. Venue attribution is reproduced from PubMed and does not imply endorsement, editorial affiliation, article quality, or scientific validity.
Bibliographic records
13 selected records.
Peptide profiles
7 connected profiles.
Publication years
7 attributed years.
Attributed bibliography
Selected records
Semaglutide · 2026 04 17
Semaglutide Treatment in Young Adults Living With Type 2 Diabetes: A Post Hoc Analysis From the SUSTAIN and PIONEER Clinical Trials.
Journal Article, Randomized Controlled Trial
Open attributed record →Glucagon · 2026 04 15
GLP-1, GIP, and Glucagon Excursions During a Mixed Meal Tolerance Test in Young and Lean South Asians Versus Europids.
Clinical Trial, Comparative Study, Journal Article
Open attributed record →Tirzepatide · 2026 04 07
Real-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP Study.
Journal Article, Multicenter Study, Observational Study
Open attributed record →Glucagon · 2026 03 12
Incretin and Glucagon Signalling in MASLD and MASH: Integrating Metabolic Pathways With Disease Progression.
Journal Article, Review
Open attributed record →Tirzepatide · 2026 02 18
Tirzepatide on physical function in adults with overweight or obesity: A systematic review and meta-analysis.
Systematic Review, Journal Article, Meta-Analysis
Open attributed record →Dulaglutide · 2025 06 24
Inequity in adherence to empagliflozin and dulaglutide for type 2 diabetes in Aotearoa New Zealand.
Letter
Open attributed record →Liraglutide · 2024 05 17
Total and H-specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration.
Journal Article, Clinical Trial
Open attributed record →Dulaglutide · 2021 12 19
Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials.
Journal Article, Research Support, Non-U.S. Gov't
Open attributed record →Lixisenatide · 2020 09 03
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis.
Journal Article, Research Support, Non-U.S. Gov't, Systematic Review, Network Meta-Analysis
Open attributed record →Dulaglutide · 2019 03 29
Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7).
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
Open attributed record →Dulaglutide · 2019 01 20
Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients.
Journal Article
Open attributed record →Exenatide · 2009 09 16
The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics.
Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
Open attributed record →